HOME >> BIOLOGY >> NEWS
Developed/emerging market biotech firms convene at largest-ever meeting with global health focus

Toronto will host a conference May 2-4 of 30 leading North American health biotechnology firms with over 30 counterparts from developing countries the biggest-ever known assembly of emerging market biotech companies to focus on global health problems.

The goals are to:

  • Foster potential collaborations between the North American and emerging market health biotech industries through company presentations and partnering events; and

  • Help global health community leaders better appreciate how developing countries home-grown biotech sectors are building capacity to create innovative, locally-relevant drugs, vaccines and other health-related products.

Organized by the McLaughlin-Rotman Centre for Global Health, University Health Network and the University of Toronto, this three-day conference convenes leaders from the global health community and executives of biotechnology firms from India, China, Brazil, South Africa, Canada, and the United States, creating opportunity for potential collaborations and partnering.

Opening day discussions will center on strategies for developing innovative products to meet health needs in developing countries. Days two and three will serve primarily as a partnering opportunity, to foster networking, information exchange and learning.

Conference sessions take place at the MaRS Discovery District, 101 College Street, Toronto

Plenary speakers and their topics include:

Weds. May 2

"Mobilizing the Private Sector for Global Health Development."
Carol H. Dahl, Ph.D., Chief of Staff, Global Health Program & Director, Global Health Technologies, Bill & Melinda Gates Foundation.

"Strategies for Developing Health Products for the Bottom of the Pyramid."
C.K. Prahalad, Professor, University of Michigan.

Friday, May 4

"Health Biotechnology Innovation in Developing Countries: a Chinese Entre
'"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health
25-Apr-2007


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Swarming starlings help probe plasma, crowds and stock market
3. Female ticks have market on gluttony
4. Nanotech leaders explore paths from research lab to marketplace
5. Commercial marketing in schools may discourage healthy nutrition environment for students
6. Environmental markets theme for February meeting in Houston
7. Genomatix appoints distributor for the growing Chinese market
8. Do green markets actually lead to improvements in environmental quality?
9. Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market
10. Mercury sponge technology goes from lab to market
11. McMaster professor leads search for holy grail of green marketing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... , ... June 22, 2020 , ... The field of ... ligand binding assays (LBA) have dominated this area. However, the use of mass spectrometry ... , This now necessitates the question “How do you choose which approach to use ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
(Date:6/19/2020)... ... June 18, 2020 , ... Biosero ... Data Decisions,” for pharmaceutical and biotech executives, laboratory managers, scientists, researchers and ... instruments and laboratory equipment from dozens of manufacturers into their lab. , ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... Bode ... significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . ... , Bode-CARES provides a turnkey solution that includes a comprehensive ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico ... patient's condition, treatment may be offered IV, intrathecal or with a combination. , A ... and the incidence continues to increase as individuals live longer. There is no cure, ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... today announced that the launch of a new clinical diagnostics immuno-oncology ... the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids ...
(Date:6/28/2020)... SILVER SPRING, Md. (PRWEB) , ... June 26, ... ... the leading trade association representing security solutions providers, today announced its strong opposition ... . , The bill would impose a blanket ban on most federal use ...
Breaking Biology Technology:
Cached News: